AGA Clinical Practice Update on Approach to the Use of Noninvasive Colorectal Cancer Screening Options: Commentary

AGA Clinical Practice Update on Approach to the Use of Noninvasive Colorectal Cancer Screening Options: Commentary

The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update Commentary is to review the available evidence and provide expert advice regarding the approach to using noninvasive colorectal cancer (CRC) screening options, including evidence for their effective...

Full description

Bibliographic Details
Main Authors:	Burke, C.A (Author), Feuerstein, J.D (Author), Lieberman, D. (Author)
Format:	Article
Language:	English
Published:	W.B. Saunders 2022
Subjects:	adenoma Adenoma blood chemistry Colorectal Cancer Screening Colorectal Neoplasms colorectal tumor DNA DNA methylation DNA Methylation early cancer diagnosis Early Detection of Cancer Fecal Immunochemical Testing feces Feces genetics human Humans Multi-Target Stool DNA Testing occult blood Occult Blood patient selection Patient Selection practice guideline Practice Guidelines as Topic procedures risk assessment Risk Assessment septin SEPTIN9 protein, human Septins urine
Online Access:	View Fulltext in Publisher

Similar Items

Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
by: Li Xie, et al.
Published: (2018-07-01)

Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
by: Eunate Arana-Arri, et al.
Published: (2017-08-01)

Is methylation analysis of SFRP2, TFPI2, NDRG4, and BMP3 promoters suitable for colorectal cancer screening in the Korean population?
by: Soo-Kyung Park, et al.
Published: (2017-10-01)

Sangre oculta en heces fecales: un valioso auxiliar en el diagnóstico precoz del cáncer colorrectal
by: Irma Martín Alvarez, et al.

Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model
by: Wen-Chih Wu, et al.
Published: (2013-01-01)

Reduced nuclear DNA methylation and mitochondrial transcript changes in adenomas do not associate with mtDNA methylation
by: M. J. Morris, et al.
Published: (2018-12-01)

Colorectal cancer screening: tests, strategies and perspectives
by: Fabrizio eStracci, et al.
Published: (2014-10-01)

The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
by: Jie Sun, et al.
Published: (2019-05-01)

Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”
by: Ahlquist DA
Published: (2017-08-01)

ADVANCES IN FAECAL DNA TESTING FOR COLORECTAL CANCER SCREENING: A LITERATURE REVIEW FOR PRIMARY CARE PROVIDERS
by: Louise Babikow, et al.
Published: (2018-03-01)

A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility
by: Justina Ucheojor Onwuka, et al.
Published: (2020-07-01)

Faecal DNA Testing for Detection of Colorectal Carcinoma: A Prospective Case Control Study
by: Mahim Koshariya, Alex Sharon, M.C. Songra, Shikha Shukla, Vidhu Khare, Kunal Vaidya, Fahad Ansari
Published: (2020-08-01)

Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study
by: James J. Goedert, et al.
Published: (2015-06-01)

Feasibility of Methylated CLIP4 in Stool for Early Detection of Colorectal Cancer: A Training Study in Chinese Population
by: Yang Cao, et al.
Published: (2021-04-01)

A novel cell‐free DNA methylation‐based model improves the early detection of colorectal cancer
by: Xianrui Wu, et al.
Published: (2021-10-01)

Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening
by: Guodong Zhao, et al.
Published: (2019-09-01)

Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care
by: Davies, J., et al.
Published: (2022)

Physician‐office vs home uptake of colorectal cancer screening using FOBT/FIT among screening‐eligible US adults
by: Onyema Greg Chido‐Amajuoyi, et al.
Published: (2019-12-01)

Methylation pattern of SFRP1 promoter in stool sample is a potential marker for early detection of colorectal cancer
by: R Salehi, et al.
Published: (2012-01-01)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
by: Laura F. Gruner, et al.
Published: (2021-03-01)

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
by: Brenner H, et al.
Published: (2017-07-01)

Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial
by: Natalie Dodd, et al.
Published: (2019-10-01)

Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016
by: Aysha Almansoori, et al.
Published: (2021-08-01)

Étude de la septine 9 et des phosphoinositides dans la cancérogénèse hépatique
by: Peng, Juan
Published: (2017)

Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients
by: Mercedes Navarro, et al.
Published: (2019-05-01)

POPULATION BASED COLORECTAL CANCER SCREENING: COMPARISON OF TWO FAECAL OCCULT BLOOD TESTS
by: Miren Begoña eZubero, et al.
Published: (2014-01-01)

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
by: Tae Jeong Oh, et al.
Published: (2017-12-01)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
by: Zhang W, et al.
Published: (2021-04-01)

Colorectal cancer, screening: achievements и opportunities
by: E. A. Polyanskaya, et al.
Published: (2018-12-01)

Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge
by: Audelaure Junca, et al.
Published: (2020-06-01)

Factors for effective colorectal cancer screening
by: Davorin Dajčman
Published: (2006-12-01)

The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas
by: Xiaofeng Li, et al.
Published: (2017-01-01)

Tugging at the Heart Strings: The Septin Cytoskeleton in Heart Development and Disease
by: Kelsey Moore, et al.
Published: (2020-01-01)

Significance of fecal hemoglobin concentration for predicting risk of colorectal cancer after colonoscopy
by: Takuji Kawamura, et al.
Published: (2020-10-01)

KCNQ5 and C9orf50 Methylation in Stool DNA for Early Detection of Colorectal Cancer
by: Yaping Cao, et al.
Published: (2021-01-01)

Faecal immunochemical tests for the diagnosis of symptomatic colorectal cancer in primary care: the benefit of more than one sample
by: Cecilia Högberg, et al.
Published: (2017-10-01)

Promoter hypermethylation of tumor related genes in the progression of colorectal neoplasia.
Published: (2005)

Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer
by: Olalla Otero-Estévez, et al.
Published: (2020-06-01)

Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study
by: Eva Lykke Toft, et al.
Published: (2019-04-01)

Use and abuse of fecal occult blood tests: a community hospital experience
by: Sarthak Soin, et al.
Published: (2019-09-01)